Approval · Notice of Compliance 14290 · 2013
ENABLEX: Notice of Compliance 14290
Issued April 16, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14290
- Date
- April 16, 2013
- Company
- Merus Labs Luxco S. A R.L.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Muscarinic me selective receptor antagonist
Products in this notice
Medicinal ingredients
- DARIFENACIN HYDROBROMIDE 7.5 MG per TAB
- DARIFENACIN HYDROBROMIDE 15 MG per TAB